Belarusian State Medical University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Minsk Belarus (1930)

Organization Overview

First Clinical Trial
2009
NCT04457037
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Associate professor, Belarusian State Medical University | Belarusian state medical university | Belarusian State Medical University | Belarussian State Medical University, Minsk, Belarus | Head of 2 Department of Surgical Diseases of BSMU | Head of 2nd Department of Surgical Diseases of BSMU | Head of the chair, Belarusian State Medical University | Head of the Department of eyes diseases of Belarusian State Medical University | Head of the Lab of Institute of Biophysics and Cell Engineering | Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | Minsk Scientific Practical Center of Surgery, Transplantation and Hematology, Belarus

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Burns (Phase 2)

Chronic Periodontitis (Phase 2)

Corneal Diseases (Phase 2)

Corneal Ulcer (Phase 2)

Endometritis (Phase 2)

Enuresis (Phase 2)

Febrile Neutropenia (Phase 4)

Gynatresia (Phase 2)

Hematologic Neoplasms (Phase 4)

Lung Diseases, Interstitial (Phase 2)

Lupus Erythematosus, Systemic (Phase 2)

Multiple Myeloma (Phase 4)

Neoplasms, Plasma Cell (Phase 4)

Neutropenia (Phase 4)

Pancreatic Neoplasms (Phase 2)

Periodontitis (Phase 2)

Pneumococcal Infections (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Pneumococcal (Phase 4)

Pneumonia, Viral (Phase 2)

Ulcer (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Urinary Incontinence (Phase 2)

Urinary Incontinence, Stress (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial APIs: 18